Dupilumab increases aspirin tolerance in NSAID-exacerbated respiratory disease.

Eur Respir J · 2023 · PMC10017890 · PMID 36549708

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Furthermore, the spirometry-derived parameters FEV 1 % predicted (+2.28±5.44%, p=0.01) and MEF 50 (+0.26±0.79, p=0.02) showed a trend towards improvement ( figure 2f , g).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.